Compare FTI & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTI | DGX |
|---|---|---|
| Founded | 1884 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.6B | 23.2B |
| IPO Year | 2016 | 1996 |
| Metric | FTI | DGX |
|---|---|---|
| Price | $76.48 | $229.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $65.50 | ★ $214.38 |
| AVG Volume (30 Days) | ★ 3.8M | 928.9K |
| Earning Date | 04-30-2026 | 04-21-2026 |
| Dividend Yield | 0.26% | ★ 1.82% |
| EPS Growth | ★ 20.42 | 13.78 |
| EPS | 0.64 | ★ 5.08 |
| Revenue | $9,932,600,000.00 | ★ $11,035,000,000.00 |
| Revenue This Year | $8.49 | $7.53 |
| Revenue Next Year | $5.53 | $3.77 |
| P/E Ratio | $118.78 | ★ $101.73 |
| Revenue Growth | 9.35 | ★ 11.78 |
| 52 Week Low | $34.27 | $165.78 |
| 52 Week High | $77.78 | $237.78 |
| Indicator | FTI | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 68.77 | 74.25 |
| Support Level | $69.25 | $190.42 |
| Resistance Level | $77.78 | N/A |
| Average True Range (ATR) | 1.98 | 6.55 |
| MACD | 0.68 | 1.76 |
| Stochastic Oscillator | 89.73 | 83.55 |
TechnipFMC PLC is the key provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies. Geographically it operates in Latin America generating the maximum revenue, then Europe and Central Asia, Africa, North America, Asia Pacific and Middle East.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.